Human Genome Sciences, Inc. (HGSI) Tops Q4 EPS by 2c

Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q4 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $45.5 million versus the consensus estimate of $42.65 million.

For earnings history and earnings-related data on Human Genome Sciences, Inc. (HGSI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'